Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5579)
All Articles published online
|
Publishing Process of This Article
|
Oct 15, 2019 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen ZX, Chen YL, Huang XM, Lin XT, He XW, Lan P. Risk factors for recurrence after bowel resection for Crohn’s disease. World J Gastrointest Pharmacol Ther 2019; 10(4): 67-74 [PMID: 31692953 DOI: 10.4292/wjgpt.v10.i4.67] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i4/67.htm |
| Number | Citing Articles |
| 1 |
Wei-Song Shen, Xiao-Hui Huang, Rui-Qing Liu, Chen-Yang Li, Yi Li, Wei-Ming Zhu. Perforating and nonperforating indications in repeated surgeries for Crohn’s disease. World Journal of Clinical Cases 2022; 10(9): 2733-2742 doi: 10.12998/wjcc.v10.i9.2733
Abstract(442) |
Core Tip(266) |
Full Article(HTML)(1129)
|
Full Article (PDF)-785K(150)
|
Full Article (Word)-282K(72)
|
Audio-774K(1)
|
Peer-Review Report-468K(51)
|
Answering Reviewers-634K(66)
|
Times Cited (0)
|
Total Visits (5384)
|
Open
|
| 2 |
Wei-Song Shen, Xiao-Hui Huang, Rui-Qing Liu, Chen-Yang Li, Yi Li, Wei-Ming Zhu. Perforating and nonperforating indications in repeated surgeries for Crohn’s disease. World Journal of Clinical Cases 2022; 10(9): 2731 doi: 10.12998/wjcc.v10.i9.2731
|
| 3 |
Javier P. Gisbert, María Chaparro. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease. Drugs 2023; 83(13): 1179 doi: 10.1007/s40265-023-01916-2
|
| 4 |
A. V. Poletova, M. V. Shapina. Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence. Meditsinskiy sovet = Medical Council 2020; (15): 128 doi: 10.21518/2079-701X-2020-15-128-133
|
| 5 |
Enhao Wu, Ming Duan, Jianqiu Han, Hanzhe Zhang, Yan Zhou, Lei Cao, Jianfeng Gong, Zhen Guo, Yi Li, Weiming Zhu. Patients with Crohn's Disease Undergoing Abdominal Surgery: Clinical and Prognostic Evaluation Based on a Single‐Center Cohort in China. World Journal of Surgery 2022; 46(2): 450 doi: 10.1007/s00268-021-06366-z
|